A Randomized, Single-Dose, Single-Sequence, Two-Arm (Fasting and Fed), Open-Label Study on the Oral Pharmacokinetics of a Nanodispersible Cannabidiol Solution (150 mg/mL)
The nanodispersible CBD oral solution showed enhanced bioavailability under fed conditions and was well tolerated in healthy subjects. Food intake increased CBD's C<sub>max</sub> and AUC and delayed T<sub>max</sub>. Further studies are required to confirm the therapeutic efficacy in patient populations.
Institutions
- PharmaSeq (United States) (US)
- Asha Hospital (IN)
- IBC Pharmaceuticals (India) (IN)
Publication Details
- Journal
- Medical Cannabis and Cannabinoids
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1159/000550104
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00